Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.11889/5384
DC FieldValueLanguage
dc.contributor.authorAli, Bahaa E-
dc.contributor.authorRabba, Abdullah K-
dc.contributor.authorFayed, Mohamed H-
dc.contributor.authorEl-Say, Khalid M-
dc.contributor.authorAnwer, Mohammad Khalid-
dc.contributor.authorAnsari, Mohammad Javed-
dc.contributor.authorAl-Shdefat, Ramadan-
dc.contributor.authorGabr, Gamal A-
dc.date.accessioned2018-03-07T09:48:35Z-
dc.date.available2018-03-07T09:48:35Z-
dc.date.issued2016-04-
dc.identifier.urihttp://hdl.handle.net/20.500.11889/5384-
dc.description.abstractPurpose: To develop and optimise some variables that influence fluoxetine orally disintegrating tablets (ODTs) formulation. Methods: Fluoxetine ODTs tablets were prepared using direct compression method. Three-factor, 3- level Box-Behnken design was used to optimize and develop fluoxetine ODT formulation. The design suggested 15 formulations of different lubricant concentration (X1), lubricant mixing time (X2), and compression force (X3) and then their effect was monitored on tablet weight (Y1), thickness (Y2), hardness (Y3), % friability (Y4), and disintegration time (Y5). Results: All powder blends showed acceptable flow properties, ranging from good to excellent. The disintegration time (Y5) was affected directly by lubricant concentration (X1). Lubricant mixing time (X2) had a direct effect on tablet thickness (Y2) and hardness (Y3), while compression force (X3) had a direct impact on tablet hardness (Y3), % friability (Y4) and disintegration time (Y5). Accordingly, Box-Behnken design suggested an optimized formula of 0.86 mg (X1), 15.3 min (X2), and 10.6 KN (X3). Finally, the prediction error percentage responses of Y1, Y2, Y3, Y4, and Y5 were 0.31, 0.52, 2.13, 3.92 and 3.75 %, respectively. Formula 4 and 8 achieved 90 % of drug release within the first 5 min of dissolution test. Conclusion: Fluoxetine ODT formulation has been developed and optimized successfully using Box- Behnken design and has also been manufactured efficiently using direct compression technique.en_US
dc.language.isoen_USen_US
dc.subjectBox-Behnken experimental designen_US
dc.subjectDirect compressionen_US
dc.subjectOrally disintegrating tabletsen_US
dc.titleDevelopment and optimization of fluoxetine orally disintegrating tablets using Box-Behnken designen_US
dc.typeArticleen_US
newfileds.departmentPharmacy - Nursing and Health Professionsen_US
newfileds.item-access-typeopen_accessen_US
newfileds.thesis-prognoneen_US
newfileds.general-subjectHuman Biology, Medicine and Health Sciences | الطب والعلوم الطبيةen_US
item.fulltextWith Fulltext-
item.grantfulltextopen-
item.languageiso639-1other-
Appears in Collections:Fulltext Publications
Files in This Item:
File Description SizeFormat
2016_15_4_1.pdf421.73 kBAdobe PDFView/Open
Show simple item record

Page view(s)

109
Last Week
0
Last month
2
checked on Apr 14, 2024

Download(s)

30
checked on Apr 14, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.